Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.

Saved in:
Bibliographic Details
Title: Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.
Authors: Ntinginya, Nyanda Elias1 (AUTHOR) nelias@nimr-mmrc.org, te Brake, Lindsey2 (AUTHOR), Sabi, Issa1 (AUTHOR), Chamba, Nyasatu3,4 (AUTHOR), Kilonzo, Kajiru3,4 (AUTHOR), Laizer, Sweetness3,4 (AUTHOR), Andia-Biraro, Irene5 (AUTHOR), Kibirige, Davis6 (AUTHOR), Kyazze, Andrew Peter5 (AUTHOR), Ninsiima, Sandra5 (AUTHOR), Critchley, Julia A.7 (AUTHOR), Romeo, Renee8 (AUTHOR), van de Maat, Josephine9 (AUTHOR), Olomi, Willyhelmina1 (AUTHOR), Mrema, Lucy1 (AUTHOR), Magombola, David1 (AUTHOR), Mwayula, Issakwisa Habakkuk10 (AUTHOR), Sharples, Katrina11 (AUTHOR), Hill, Philip C.11 (AUTHOR), van Crevel, Reinout9,12 (AUTHOR)
Source: Trials. 6/10/2022, Vol. 23 Issue 1, p1-16. 16p. 6 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-022-06296-8